Bonnet MMB, Bhatt NB, Baudin E, Silva C, Michon C, et al.
2013-04-01 • Lancet Infectious Diseases
2013-04-01 • Lancet Infectious Diseases
BACKGROUND In countries with a high incidence of HIV and tuberculosis co-infection, nevirapine and efavirenz are widely used as antiretroviral therapy but both interact with antitube...
Bonnet MMB, Baudin E, Jani IV, Nunes E, Verhoustraeten F, et al.
2013-12-18 • PLOS One
2013-12-18 • PLOS One
OBJECTIVES AND DESIGN We used data from a randomized trial of HIV-tuberculosis co-infected patients in Mozambique to determine the incidence and predictors of paradoxical tuberculosi...
Baudin E, Bhatt NB, Rouzioux C, Serafini M, Molfino L, et al.
2019-02-08 • F1000Research
2019-02-08 • F1000Research
BACKGROUND In the CARINEMO ANRS 12146 clinical trial, HIV-tuberculosis co-infected patients in Mozambique were randomized to nevirapine (NVP) or to efavirenz (EFV)-based antiretrovir...
Bhatt NB, Barau C, Amin A, Baudin E, Meggi B, et al.
2014-03-24 • Antimicrobial Agents and Chemotherapy
2014-03-24 • Antimicrobial Agents and Chemotherapy
This is a substudy of the Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS) Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patien...
Bhatt NB, Gudo ES, Sema C, Bila D, Di Mattei P, et al.
2009-12-01 • International Journal of STD and AIDS
2009-12-01 • International Journal of STD and AIDS
Seven hundred and four HIV-1/2-positive, antiretroviral therapy (ART) naïve patients were screened for HTLV-1 infection. Antibodies to HTLV-1 were found in 32/704 (4.5%) of the patients....
Bhatt NB, Baudin E, Meggi B, da Silva C, Barrail-Tran A, et al.
2014-09-18 • Journal of Antimicrobial Chemotherapy
2014-09-18 • Journal of Antimicrobial Chemotherapy
OBJECTIVES We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12...
